Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Back
Association details:
Biomarker:
ALK G1123S
Cancer:
Non Small Cell Lung Cancer
Drug:
Zykadia (ceritinib)
(
ALK inhibitor
)
Direction:
Resistant
Evidence:
Evidence Level:
Resistant: C4 – Case Studies
New
Source:
J Thorac Oncol
Title:
Identification of a Novel ALK G1123S Mutation in a Patient with ALK-rearranged Non–small-cell Lung Cancer Exhibiting Resistance to Ceritinib
Excerpt:
In summary, the G1123S mutation was identified in a patient with ALK+ non–small-cell lung cancer exhibiting resistance to ceritinib.
DOI:
10.1097/JTO.0000000000000509
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login